Sign in to continue:

Thursday, March 12th, 2026

LifeMD, Inc. 2025 Annual Report: Virtual Healthcare, Telehealth Growth, and Integrated Pharmacy Platform 101

  • Company Status and Regulatory Filing:

    • LifeMD is not a well-known seasoned issuer and is not an emerging growth company.
    • It has complied with all SEC filing requirements and submitted all Interactive Data Files as required.
  • Shareholder and Market Information:

    • Common Stock: Par value \$0.01 per share, trading under symbol LFMD on Nasdaq.
    • Preferred Stock: Series A Cumulative Perpetual Preferred Stock (8.875%, par value \$0.0001 per share), trading under symbol LFMDP on Nasdaq.
    • Public Float: \$512,472,017 as of June 30, 2025.
    • Outstanding Shares: 47,973,844 shares as of March 9, 2026.
  • Incorporated Documents:

    • Portions of the 2026 definitive proxy statement, to be filed within 120 days of year-end, are incorporated by reference. This may contain details about board changes, executive compensation, and governance that could affect share value.
  • View LifeMD, Inc. Historical chart here



    LightPath Technologies, Inc. Form 8-K SEC Filing Details and XBRL Data (February 2026)

    LightPath Technologies, Inc. - Investor Day & Regulation FD ...

    Berkshire Hathaway Inc. 2025 Annual 10-K Report: Business Segments, Financial Data, and Key Disclosures

    Berkshire Hathaway Inc. 2025 Annual Report: Key Insights for...

    PreAxia Health Care Payment Systems Inc. 8-K/A Amendment Filing – Accountant Change & Sadler Gibb Letter (Feb 2026)

    PreAxia Health Care Payment Systems Inc. 8-K/A Detailed Inve...

       Ad